Total Holdings
58
Portfolio diversification across 58 positions
CANC
(NASDAQ)Tema Oncology ETF
$37.11-- (--)
Loading... - Market loading
CANC ETF Holdings: Tema Oncology ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$165.84M
Total fund assets
Expense Ratio
0.75%
Annual management fee
Fund Issuer
Tema
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Revolution Medicines, Inc | Stock | 6.62% |
| 2 |  | BridgeBio Pharma, Inc | Stock | 5.00% |
| 3 | S SWX:NOVN | Novartis AG | Stock | 4.97% |
| 4 | L LSE:AZN | AstraZeneca PLC | Stock | 4.75% |
| 5 | L LON:AZN | AstraZeneca PLC | Stock | 4.51% |
| 6 |  | Eli Lilly and Company | Stock | 4.39% |
| 7 | B BMY | Bristol-Myers Squibb Company | Stock | 4.26% |
| 8 | O OTCQX:RHHBY | Roche Holding AG | Stock | 4.21% |
| 9 | O OTC:RHHBY | Roche Holding AG | Stock | 4.18% |
| 10 |  | Merck & Co., Inc | Stock | 3.95% |
| 11 |  | Cogent Biosciences, Inc. | Stock | 3.76% |
| 12 |  | Immunome, Inc. | Stock | 3.65% |
| 13 |  | Nuvalent Inc | Stock | 3.35% |
| 14 |  | Genmab A/S | Stock | 3.20% |
| 15 |  | Johnson & Johnson | Stock | 3.09% |
| 16 |  | Celcuity Inc. | Stock | 3.04% |
| 17 |  | AbbVie Inc. | Stock | 2.60% |
| 18 |  | Exelixis, Inc. | Stock | 2.50% |
| 19 |  | Amgen Inc | Stock | 2.48% |
| 20 |  | CG Oncology, Inc. | Stock | 2.48% |
| 21 |  | Arcellx Inc | Stock | 2.35% |
| 22 |  | Erasca, Inc. | Stock | 2.22% |
| 23 |  | Zai Lab Limited | Stock | 2.20% |
| 24 | M MUTF:FXFXX | First American Treasury Obligations Fund | Stock | 2.16% |
| 25 |  | IDEAYA Biosciences, Inc. | Stock | 2.15% |
| 26 |  | BeOne Medicines AG | Stock | 2.08% |
| 27 | B BGNE | BeiGene, Ltd | Stock | 2.07% |
| 28 |  | Legend Biotech Corporation | Stock | 2.01% |
| 29 |  | Syndax Pharmaceuticals Inc | Stock | 1.72% |
| 30 |  | Zymeworks Inc. | Stock | 1.60% |
| 31 |  | Halozyme Therapeutics, Inc | Stock | 1.41% |
| 32 |  | Nuvation Bio Inc | Stock | 1.30% |
| 33 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 1.24% |
| 34 |  | Summit Therapeutics PLC | Stock | 1.15% |
| 35 |  | AnaptysBio, Inc | Stock | 1.04% |
| 36 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.01% |
| 37 |  | Nurix Therapeutics, Inc | Stock | 1.01% |
| 38 |  | Day One Biopharmaceuticals Inc | Stock | 0.96% |
| 39 |  | UroGen Pharma Ltd | Stock | 0.96% |
| 40 |  | Corvus Pharmaceuticals Inc | Stock | 0.94% |
| 41 |  | argenx NV ADR | Stock | 0.92% |
| 42 |  | Gilead Sciences, Inc | Stock | 0.92% |
| 43 |  | Olema Pharmaceuticals Inc | Stock | 0.88% |
| 44 |  | Relay Therapeutics, Inc | Stock | 0.82% |
| 45 |  | Terns Pharmaceuticals Inc | Stock | 0.72% |
| 46 |  | Guardant Health, Inc | Stock | 0.70% |
| 47 |  | ArriVent BioPharma, Inc. Common Stock | Stock | 0.61% |
| 48 |  | Immunocore Holdings plc | Stock | 0.61% |
| 49 |  | HUTCHMED (China) Limited | Stock | 0.61% |
| 50 |  | Xencor, Inc | Stock | 0.59% |
Frequently Asked Questions About Tema Oncology ETF Holdings
What are the top holdings in CANC?
Tema Oncology ETF (CANC) holds 58 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is CANC's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review CANC's holdings table to analyze concentration risk.
What is CANC's sector allocation?
The Sector Allocation chart shows how CANC distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does CANC invest in?
CANC's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is CANC ETF?
CANC's diversification can be assessed by reviewing its 58 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.